These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11227047)

  • 1. Testosterone in ageing men.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Expert Opin Investig Drugs; 2001 Mar; 10(3):477-92. PubMed ID: 11227047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen replacement therapy: present and future.
    Gooren LJ; Bunck MC
    Drugs; 2004; 64(17):1861-91. PubMed ID: 15329035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone supplementation: what and how to give.
    Jockenhövel F
    Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
    Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.
    Zgliczynski S; Ossowski M; Slowinska-Srzednicka J; Brzezinska A; Zgliczynski W; Soszynski P; Chotkowska E; Srzednicki M; Sadowski Z
    Atherosclerosis; 1996 Mar; 121(1):35-43. PubMed ID: 8678922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group.
    Winters SJ; Atkinson L
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):317-22. PubMed ID: 9373453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizons in testosterone and the ageing male.
    Ahern T; Wu FC
    Age Ageing; 2015 Mar; 44(2):188-95. PubMed ID: 25666224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy in men: clinical and pharmacological perspectives.
    Gambineri A; Pasquali R
    J Endocrinol Invest; 2000 Mar; 23(3):196-214. PubMed ID: 10803480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Andropause].
    Hochreiter WW; Ackermann DK; Brütsch HP
    Ther Umsch; 2005 Dec; 62(12):821-6. PubMed ID: 16405287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen replacement in aging men.
    Francis RM
    Calcif Tissue Int; 2001 Oct; 69(4):235-8. PubMed ID: 11730258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.